Searched for
ANTI DIABETES PILL
India's weight-loss drug boom raises questions over healthcare prioritiesIndia's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...- Take a pill! Novo Nordisk's Wegovy gets US' nod as daily pill for obesity treatmentNovo Nordisk's popular weight-loss drug Wegovy is now available as a pill in the US. The US Food and Drug Administration has approved the o...
- What is Ozempic 2.0? Is it the future of weight loss? Here's what you need to know about the new drugA new pill, Orforglipron, is set to revolutionize weight loss and diabetes treatment. This daily pill, developed by Eli Lilly, has shown si...
- Soon, take your pick of more OzempicsA crucial ingredient in weight loss drugs will become available as generics next year in India and other major markets. This is expected to...
- Eli Lilly says its anti-obesity pill matches OzempicEli Lilly's Orforglipron, an anti-obesity pill, demonstrated significant weight loss and blood sugar reduction in clinical trials, rivaling...
- India's anti-obesity drug market has grown more than fourfold in the last five yearsIndia's anti-obesity drug market has surged, growing over fourfold in five years, reaching ₹576 crore by March 2025, driven by lifestyle di...
- Alkem Labs denies claims of Pan-D, Clavam 625 batches being not-of-standard qualityAlkem Laboratories has denied claims that its products Pan-D and Clavam 625 are of substandard quality. The company stated that an investig...
- New oral diabetes + obesity drug's India sales surge 100%India experiences a surge in Rybelsus sales, impacting the anti-obesity market. Semaglutide dominates, reflecting India's obesity challenge...
- Novo Nordisk launches anti-diabetes pill semaglutide in IndiaNovo Nordisk, the Danish drug maker on Thursday announced the launch of oral semaglutide in India for treatment of type 2 diabetes.
- Molnupiravir not included in COVID-19 treatment guidelines as its harms outweigh benefits: ICMRNoting its rampant and irrational use of the pill, Balram Bhargava, Director General, Indian Council of Medical Research (ICMR) said that e...
- MSN Labs launches patented diabetes pill Jardiance after DRL, heats up potential legal battleEarlier, ET reported that Dr Reddy's Labs has launched copies of Jardiance. It has a valid patent in India until 2025.
- Dr Reddy's Labs launches copy of BI drug; move may lead to legal battleUnder its brand Vicra, Dr. Reddy's is expected to sell the drug in India at less than a third of the price charged by Boehringer Ingelheim....
- 'Dimpi' to the rescue of diabetics (Health Feature)Kolkata, Feb 16 (IANS) In a breakthrough that could transform the despair of diabetics into dimples of relief, Indian scientists have desig...
- High Court restrains Glenmark Pharmaceuticals from business of anti-diabetes drugsEarlier, in an interim order, a division bench of the high Court had restrained Glenmark from making or selling its drug, used for treatmen...
- MSD-Glenmark drug patent row: Delhi High Court reserves verdictThe Delhi High Court today reserved its verdict on US drug major Merck Sharp and Dohme's appeal against a single judge bench order.
- Centre bans anti-obesity drug due to side effectsThe government has banned manufacturing and sale of anti-obesity medicine Sibutramine and its combination drugs sold under various brands d...
- GSK drug-deal talk lifts DRL scripShares of Dr Reddy’s Laboratories (DRL) touched an intra-day high of Rs 878.70, amid speculation that the Indian drug maker is in prelimina...
- DRL’s anti-diabetes drug to hit market by ’11Dr Reddy’s anti-diabetes molecule Balaglitazone, which has entered the final phase of clinical development, is expected to hit the world ma...
- Lupin to diversify into therapeutic segmentsAntibiotics and speciality domestic pharma major Lupin is planning to diversify into new therapeutic segments.
- Paswan slashes prices of 886 drugsThe list includes anti-diabetic pills, antibiotics, cough syrups, pain killers and anti-hypertensives.
Load More
